Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 16 | 13 | 12 | 13 | 18 |
| Accounts receivable | -168 | -138 | 82 | -91 | -27 |
| Other Working Capital | -39 | -131 | -346 | 189 | -215 |
| Other Operating Activity | -861 | -680 | 1,675 | -501 | -379 |
| Operating Cash Flow | $-1,052 | $-936 | $1,423 | $-391 | $-604 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -8 | -10 | 0 | -4 |
| Purchase Sale Intangibles | -36 | -19 | -7 | -11 | -38 |
| Investing Cash Flow | $-42 | $-28 | $-17 | $-11 | $-42 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -500 | 0 | N/A | N/A | 0 |
| Other Financing Activity | 2,086 | -25 | -200 | 450 | 600 |
| Financing Cash Flow | $1,586 | $-25 | $-200 | $450 | $600 |
| Beginning Cash Position | 341 | 1,329 | 123 | 75 | 122 |
| End Cash Position | 834 | 341 | 1,329 | 123 | 75 |
| Net Cash Flow | $493 | $-988 | $1,206 | $47 | $-46 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,052 | -936 | 1,423 | -391 | -604 |
| Capital Expenditure | -42 | -28 | -17 | -11 | -42 |
| Free Cash Flow | -1,093 | -963 | 1,406 | -403 | -646 |